Synonyms: CAD-1883 | CAD1883 | compound 1 [US9975886B1]
Compound class:
Synthetic organic
Comment: Rimtuzalcap (CAD-1883) is a KCa2 channel activator (positive allosteric modulator) [1], that was developed for potential to treat movement disorders such as essential tremor and spinocerebellar ataxia.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-(4,4-difluorocyclohexyl)-2-(3-methylpyrazol-1-yl)-6-morpholin-4-ylpyrimidin-4-amine |
International Nonproprietary Names ![]() |
|
INN number | INN |
11140 | rimtuzalcap |
Synonyms ![]() |
CAD-1883 | CAD1883 | compound 1 [US9975886B1] |
Database Links ![]() |
|
CAS Registry No. | 2167246-24-2 (source: WQHO INN record) |
ChEMBL Ligand | CHEMBL4650330 |
GtoPdb PubChem SID | 483123197 |
PubChem CID | 132207249 |
Search Google for chemical match using the InChIKey | OVLIDRAJVMUEMC-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | OVLIDRAJVMUEMC |
Search PubMed clinical trials | rimtuzalcap |
Search PubMed titles | rimtuzalcap |
Search PubMed titles/abstracts | rimtuzalcap |
UniChem Compound Search for chemical match using the InChIKey | OVLIDRAJVMUEMC-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OVLIDRAJVMUEMC-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Rimtuzalcap (links to external site)
Cat. No. HY-109160 |